Literature DB >> 32122913

Effect of fundus tracking on structure-function relationship in glaucoma.

Giovanni Montesano1,2, Luca M Rossetti3, Allison M McKendrick4, Andrew Turpin5, Paolo Fogagnolo3, Francesco Oddone6, Paolo Lanzetta7, Andrea Perdicchi8, Chris A Johnson9, Paolo Brusini10, David F Garway-Heath2, David P Crabb11.   

Abstract

AIMS: To investigate the effect of fundus tracking perimetry on structure-function relationship in glaucoma.
METHODS: Perimetric data were acquired with the Humphrey Field Analyzer (HFA) and the Compass fundus perimeter (CMP, equipped with fundus tracking). We included data from 696 eyes from 360 healthy people and 711 eyes from 434 patients with glaucoma from the original study, for which the circumpapillary retinal nerve fibre layer optical coherence tomography scan (Cp-RNFL) was available. We explored the structure-function relationship using both global indices (mean deviation and average Cp-RNFL thickness loss) and anatomically defined visual field clusters comparing the R2 values from mixed-effect models. We then measured the diagnostic ability of a combined Structure Function Index (SFI) using perimetric data from either perimeter. The comparisons were based on partial receiver operating characteristic curves with a minimum specificity of 75% and their areas under the curve.
RESULTS: The R2 for the global structure-function relationship was 0.50 for the CMP and 0.48 for the HFA. When visual field clusters were included in the model, the R2 was 0.29 for CMP and 0.30 for HFA. Overall, the discrimination ability of the SFI was not significantly higher than the Cp-RNFL for either the CMP (p=0.07) or the HFA (p=0.14). However, it was significantly better in eyes with perimetric damage (p<0.001), in which the CMP-SFI performed significantly better than the HFA-SFI (p=0.03).
CONCLUSIONS: Structure-function relationship is similar between the two perimeters. Fundus tracking might improve discrimination ability with a combined SFI. TRIAL REGISTRATION NUMBER: ISRCTN13800424. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostic tests/investigation; glaucoma; imaging; psychophysics

Mesh:

Year:  2020        PMID: 32122913     DOI: 10.1136/bjophthalmol-2019-315070

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

Review 1.  Understanding the role of microperimetry in glaucoma.

Authors:  Luca Scuderi; Irene Gattazzo; Alessandro de Paula; Clemente Maria Iodice; Federico Di Tizio; Andrea Perdicchi
Journal:  Int Ophthalmol       Date:  2022-01-30       Impact factor: 2.029

2.  Combining Structural and Vascular Parameters to Discriminate Among Glaucoma Patients, Glaucoma Suspects, and Healthy Subjects.

Authors:  Alessandro Rabiolo; Federico Fantaguzzi; Riccardo Sacconi; Francesco Gelormini; Enrico Borrelli; Giacinto Triolo; Paolo Bettin; Andrew I McNaught; Joseph Caprioli; Giuseppe Querques; Francesco Bandello
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

3.  Comparison of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness Values Using Spectral-Domain and Swept-Source OCT.

Authors:  Alessandro Rabiolo; Federico Fantaguzzi; Giovanni Montesano; Maria Brambati; Riccardo Sacconi; Francesco Gelormini; Giacinto Triolo; Paolo Bettin; Giuseppe Querques; Francesco Bandello
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

4.  Elucidating macular structure-function correlations in glaucoma.

Authors:  Sara Giammaria; Glen P Sharpe; Oksana Dyachok; Paul E Rafuse; Lesya M Shuba; Marcelo T Nicolela; Jayme R Vianna; Balwantray C Chauhan
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

5.  Increased Depth, Reduced Extent, and Sharpened Edges of Visual Field Defects Measured by Compass Fundus Perimeter Compared to Humphrey Field Analyzer.

Authors:  Ping Liu; Bao N Nguyen; Andrew Turpin; Allison M McKendrick
Journal:  Transl Vis Sci Technol       Date:  2021-10-04       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.